Ribavirin Oral Solution Clinical Trials

• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
  ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
  Hepatitis C
  
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
  ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
  Chronic Hepatitis C
  
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
  ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
  Chronic Hepatitis C
  
• Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
  ClinicalTrials.gov Identifier: NCT00204165 - Active, not recruiting
  Magnetic Resonance Imaging, Intestine Small, Crohn Disease.
  
• Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
  ClinicalTrials.gov Identifier: NCT00532701 - Recruiting
  Chronic Hepatitis C; Genotype 2; Peginterferon; Ribavirin
  
• Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
  ClinicalTrials.gov Identifier: NCT00166842 - Active, not recruiting
  Transplantation; Kidney Transplantation; Immunosuppression
  
• Therapy with Infergen, Ribavirin, & Avandia in a Group of Insulin Resistant, Chronic Hepatitis C, Genotype 1 Patients Who Are Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
  ClinicalTrials.gov Identifier: NCT00207402 - Not yet recruiting
  Hepatitis C
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam
  ClinicalTrials.gov Identifier: NCT00319605 - Recruiting
  Epilepsy
  
• Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
  ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
  Hepatitis
  
• Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
  ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
  Chronic Hepatitis C
  
• Trial of Effects of Oral Xyrem and Zolpidem on Sleep-Disordered Breathing in Obstructive Sleep Apnea Patients
  ClinicalTrials.gov Identifier: NCT00086281 - Active, not recruiting
  Obstructive Sleep Apnea Syndrome
  
• Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00016081 - Active, not recruiting
  Infection
  
• Long-Term Therapy with Ribavirin for Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00001854 - Active, not recruiting
  Chronic Hepatitis C
  
• A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
  ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
  Hepatitis C
  
• Safety and Efficacy of Ferriprox™ (Deferiprone) Oral Solution in Iron Overloaded Pediatric Patients
  ClinicalTrials.gov Identifier: NCT00529152 - Recruiting
  Iron Overload
  
• Zidovudine Levels in HIV Infected Patients Being Treated for HCV
  ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• PEDS-C: Pegylated Interferon +/- Ribavirin for Children with Hepatitis C
  ClinicalTrials.gov Identifier: NCT00100659 - Active, not recruiting
  Chronic Hepatitis C
  
• Multicenter Study Evaluating 12 Versus 24 Weeks Therapy with Peginterferon and Ribavirin for HCV Genotype 2 or 3
  ClinicalTrials.gov Identifier: NCT00143000 - Recruiting
  Hepatitis C Virus
  
• Optical Sensor for Photodynamic Detection of Oral Pathology
  ClinicalTrials.gov Identifier: NCT00540774 - Enrolling by invitation
  Oral Diseaes; Abnormal Oral Mucosa
  
• IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
  ClinicalTrials.gov Identifier: NCT00483938 - Recruiting
  Hepatitis C, Chronic
  
• A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma
  ClinicalTrials.gov Identifier: NCT00005668 - Completed
  Aspergillosis; Lung Diseases, Fungal
  
• An Open-Label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
  ClinicalTrials.gov Identifier: NCT00465647 - Recruiting
  Acute Pain
  
• Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C with and without Kidney Disease
  ClinicalTrials.gov Identifier: NCT00028093 - Recruiting
  Hepatitis C
  
• Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
  ClinicalTrials.gov Identifier: NCT00056862 - Recruiting
  Hepatitis C
  
• PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
  ClinicalTrials.gov Identifier: NCT00390598 - Active, not recruiting
  Colonoscopy
  
• Randomised Trial of Eutectic Mixture of Local Anaesthetics Cream and Oral Sucrose Solution for Venepuncture
  ClinicalTrials.gov Identifier: NCT00470080 - Not yet recruiting
  Pain
  
• A Comparison of GV Mouth Washes,Nystatin,Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
  ClinicalTrials.gov Identifier: NCT00128323 - Active, not recruiting
  Oropharyngeal candidiasis
  
• Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00014391 - Active, not recruiting
  Leukemia; Testicular Cancer; ovarian epithelial cancer; Lymphoma; Breast Cancer; Multiple Myeloma; kidney tumor
  
• Oral Health Education Program
  ClinicalTrials.gov Identifier: NCT00103493 - Active, not recruiting
  Dental Caries; Oral hygiene; Oral health; Dental health
  
• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00099021 - Active, not recruiting
  lip and oral cavity cancer; Oropharyngeal Cancer; Oral Leukoplakia
  
• Efficacy of Prazosin Versus Placebo Associated with Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C with Genotype 1 or 4 and Severe Fibrosis
  ClinicalTrials.gov Identifier: NCT00148837 - Active, not recruiting
  Hepatitis C, Chronic; Fibrosis
  
• Fenretinide in Treating Patients with Neoplasia of the Mouth
  ClinicalTrials.gov Identifier: NCT00003223 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Ribavirin to prevent RSV pneumonia in Bone Marrow Transplant patients
  ClinicalTrials.gov Identifier: NCT00031473 - Terminated
  Respiratory Syncytial Virus Infections
  
• Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
  ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
  lip and oral cavity cancer; prevention of oral cancer
  
• Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00547053 - Recruiting
  Cystic Fibrosis
  
• Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy
  ClinicalTrials.gov Identifier: NCT00162734 - Active, not recruiting
  Chronic Hepatitis C
  
• Wild Type p53 Adenovirus for Oral Premalignancies
  ClinicalTrials.gov Identifier: NCT00410865 - Active, not recruiting
  Mouth Cancer; Dysplasia/Carcinoma in Situ (CIS) of the Oral Cavity; Dysplasia/Carcinoma in Situ (CIS) of the Oral Pharynx
  
• Oral acyclovir for neonatal HSV disease of the skin,eyes and mouth
  ClinicalTrials.gov Identifier: NCT00031447 - Active, not recruiting
  Herpes Simplex
  
• Assessment of oral acyclovir in neonates with HSV involving the CNS
  ClinicalTrials.gov Identifier: NCT00031460 - Active, not recruiting
  Herpes Simplex
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
  Hepatitis C; HIV Infections
  
• Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
  ClinicalTrials.gov Identifier: NCT00132873 - Recruiting
  Narcolepsy
  
• Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00151086 - Active, not recruiting
  Prostate Cancer
  
• Expression of Hypoxia-Inducible Factor-α in Oral Precancers and Cancers
  ClinicalTrials.gov Identifier: NCT00154973 - Recruiting
  Oral Cancer
  
• Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
  ClinicalTrials.gov Identifier: NCT00250289 - Recruiting
  Halitosis; Oral Malodor; Bad Breath
  
• A Study to Evaluate the Efficacy and Safety of Albuferon and Ribavirin in Interferon Naive Subjects with Chronic Hepatitis C Genotype 1
  ClinicalTrials.gov Identifier: NCT00115908 - Completed
  Hepatitis C, Chronic
  
• Study to Evaluate Drug-Drug Interaction Between Valopicitabine and Ribavirin
  ClinicalTrials.gov Identifier: NCT00395421 - Active, not recruiting
  Chronic Hepatitis C
  
• Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4
  ClinicalTrials.gov Identifier: NCT00277862 - Active, not recruiting
  Hepatitis C
  
• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
  ClinicalTrials.gov Identifier: NCT00323518 - Active, not recruiting
  Oral Mucositis; Stomatitis
  
• Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C
  ClinicalTrials.gov Identifier: NCT00203606 - Active, not recruiting
  Hepatitis C
  
• Smoking Status and Body Image in Oral Cancer Patients
  ClinicalTrials.gov Identifier: NCT00412490 - Active, not recruiting
  Oral Cavity Cancer
  
• Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00006341 - Active, not recruiting
  oral complications of cancer and cancer therapy; stage III lip and oral cavity cancer; stage II lip and oral cavity cancer; Quality of Life; ...
  
• An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.
  ClinicalTrials.gov Identifier: NCT00002133 - Completed
  Candidiasis, Oral; HIV Infections
  
• Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy
  ClinicalTrials.gov Identifier: NCT00299923 - Active, not recruiting
  Hepatitis C, Chronic; Relapse
  
• Laser Therapy in Preventing Oral Mucositis in Patients Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00024037 - Active, not recruiting
  oral complications of cancer and cancer therapy
  
• Ribavirin, Its Dosing Regime
  ClinicalTrials.gov Identifier: NCT00484328 - Recruiting
  Hepatitis C
  
• Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
  ClinicalTrials.gov Identifier: NCT00117533 - Recruiting
  Chronic Hepatitis B; Chronic Hepatitis D
  
• Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00002747 - Active, not recruiting
  stage IV squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity; ...
  
• Study in Non-Responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin
  ClinicalTrials.gov Identifier: NCT00230854 - Active, not recruiting
  Chronic Hepatitis C; Hepatitis, Viral, Human
  
• Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer
  ClinicalTrials.gov Identifier: NCT00042926 - Active, not recruiting
  stage I squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the lip and oral cavity
  
• Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
  ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
  Chronic Hepatitis C
  
• Three Regimens of PEG-Intron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548AM2)
  ClinicalTrials.gov Identifier: NCT00302081 - Active, not recruiting
  Hepatitis C, Chronic
  
• Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00421434 - Active, not recruiting
  Chronic Hepatitis C
  
• Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
  ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
  Hepatitis C, Chronic
  
• Intermittent Use of Aerosolized Ribavirin for Treatment of RSV
  ClinicalTrials.gov Identifier: NCT00500578 - Recruiting
  Hematological Malignancies
  
• Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003139 - Active, not recruiting
  oral complications of cancer and cancer therapy; oropharyngeal squamous cell carcinoma; lip and oral cavity squamous cell carcinoma
  
• 48 Weeks Combination Therapy for Patients with HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
  ClinicalTrials.gov Identifier: NCT00114361 - Active, not recruiting
  Hepatitis B
  
• An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
  ClinicalTrials.gov Identifier: NCT00292084 - Active, not recruiting
  Hepatitis C, Chronic
  
• Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive
  ClinicalTrials.gov Identifier: NCT00230958 - Active, not recruiting
  Chronic Hepatitis C
  
• Study to Evaluate Viral Kinetics in the First 12 Weeks of Patients With Hepatitis C Coinfected With HIV Treated With Induction Doses of Peginterferon Alpha-2a (40 KD) and Ribavirin With Epoetin β Support
  ClinicalTrials.gov Identifier: NCT00356486 - Active, not recruiting
  HIV Infections
  
• A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection.
  ClinicalTrials.gov Identifier: NCT00353418 - Active, not recruiting
  Hepatitis C, Chronic
  
• Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00154869 - Recruiting
  Patients with dual chronic hepatitis B and C
  
• Pediatric Expanded Access Program-Oral Solution
  ClinicalTrials.gov Identifier: NCT00543530 - Completed
  HIV Infections
  
• Influence of Ribavirin and Interferon on Semen Quality, IRIS Study
  ClinicalTrials.gov Identifier: NCT00455832 - Recruiting
  Sperm Motility
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• A Peri-Intubation Oral Intervention to Reduce Oral Flora and VAP
  ClinicalTrials.gov Identifier: NCT00248300 - Recruiting
  Pneumonia
  
• Effects of Oral Care in the Neuroscience ICU
  ClinicalTrials.gov Identifier: NCT00518752 - Recruiting
  Ventilator Associated Pneumonia; Oral Hygiene
  
• Fluorescence & Reflectance Imaging to Detect Oral Neoplasia
  ClinicalTrials.gov Identifier: NCT00542373 - Recruiting
  Oral Cancer
  
• Oral Budesonide vs. Oral Mesalazine in Active CD
  ClinicalTrials.gov Identifier: NCT00300118 - Recruiting
  Crohn's Disease
  
• Efficacy and Safety Study for an Oral Contraceptive Containing Folate
  ClinicalTrials.gov Identifier: NCT00468481 - Recruiting
  Oral Contraception
  
• Intraoral Grafting of Ex Vivo Produced Oral Mucosal Composites
  ClinicalTrials.gov Identifier: NCT00000111 - Active, not recruiting
  Mouth Diseases
  
• A Randomized Study of Sulindac in Oral Premalignant Lesions
  ClinicalTrials.gov Identifier: NCT00299195 - Recruiting
  Leukoplakia, Oral; Benign Neoplasms
  
• Fluorescence and Reflectance Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00507182 - Recruiting
  Oral Cancer
  
• Dexamethasone 0.01% Solution for the Treatment of Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00111072 - Completed
  
  
• Evaluation of a Multispectral Vision Enhancement System for Assessment of Oral Mucosal Lesions
  ClinicalTrials.gov Identifier: NCT00502580 - Recruiting
  Oral Cancer
  
• In Vivo Confocal Imaging of Oral Mucosa
  ClinicalTrials.gov Identifier: NCT00502125 - Recruiting
  Oral Tumors
  
• Efficacy of Elidel Cream on Erosive Oral Lichen Planus
  ClinicalTrials.gov Identifier: NCT00130572 - Recruiting
  Lichen Planus, Oral
  
• Changes in Oral Vitamin K Intake for Optimization of Chronic Oral Anticoagulation: A Randomized Trial
  ClinicalTrials.gov Identifier: NCT00355290 - Recruiting
  Blood Coagulation Disorders
  
• Fenretinide in Treating Patients With Leukoplakia of the Mouth
  ClinicalTrials.gov Identifier: NCT00004161 - Active, not recruiting
  prevention of oral cancer
  
• RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin
  ClinicalTrials.gov Identifier: NCT00485342 - Recruiting
  Chronic Hepatitis C
  
• Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in HCV-Genotype-1-Infection (PRAMA)
  ClinicalTrials.gov Identifier: NCT00127777 - Active, not recruiting
  Hepatitis C, Chronic
  
• Elective vs Therapeutic Neck Dissection in the Treatment of Early Node Negative Squamous Carcinoma of the Oral Cavity
  ClinicalTrials.gov Identifier: NCT00193765 - Recruiting
  Oral Cancer
  
• Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
  ClinicalTrials.gov Identifier: NCT00323219 - Recruiting
  Cellulitis
  
• Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study)
  ClinicalTrials.gov Identifier: NCT00484822 - Recruiting
  Long-Term Oral Anticoagulant Therapy
  
• Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin
  ClinicalTrials.gov Identifier: NCT00382798 - Recruiting
  Healthy Volunteers; Hepatitis C Virus
  
• Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
  ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
  Hepatitis C
  
• Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003327 - Active, not recruiting
  Nose Cancer; Oral Cancer